Insulin and Metformin are Associated With Reduced Risk of Amyotrophic Lateral Sclerosis
Abstract Background Type 2 diabetes (T2D), but not type 1, protected against amyotrophic lateral sclerosis (ALS). In T2D serum insulin is normal or elevated in the early stages. Type 1 diabetes, characterized by a total lack of insulin, is associated with an increased risk of ALS. The antidiabetic m...
Saved in:
| Main Authors: | Steven Lehrer, Peter H. Rheinstein |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Chronic Diseases and Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/cdt3.141 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The landscape of non-reference SINE-VNTR-Alus in amyotrophic lateral sclerosis
by: Abigail L. Pfaff, et al.
Published: (2025-05-01) -
Retrotransposition-competent L1s are increased in the genomes of individuals with amyotrophic lateral sclerosis
by: Abigail L. Pfaff, et al.
Published: (2025-06-01) -
Pain in Amyotrophic Lateral Sclerosis Is Underrated
by: Soyoung Kwak, et al.
Published: (2024-12-01) -
Motor Neuron Disease: The Contribution of TAR-43 Gene in Amyotrophic Lateral Sclerosis
by: Gorky Guha
Published: (2023-08-01) -
Emerging biomarkers in amyotrophic lateral sclerosis: from pathogenesis to clinical applications
by: Farah Anjum, et al.
Published: (2025-06-01)